Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Glioma × niraparib × Clear all

Phase

Phase EARLY_PHASE1 2 Phase 2 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 5 Fallopian Tube Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Neoplasms 2 Advanced Solid Tumor 2 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Pancreatic Adenocarcinoma 1 Oropharyngeal Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Laryngeal Diseases 1 Glioma 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Advanced Solid Tumor, Adult 1

Interventions

Temozolomide 24 Radiotherapy 10 Bevacizumab 10 Carboplatin 6 pembrolizumab 4 Radiation 4 Nivolumab 4 Irinotecan 4 IL13-PE38 4 Surgical Procedures, Operative 3 Erlotinib Hydrochloride 3 Aminolevulinic Acid 3 trametinib 2 temsirolimus 2 fludarabine 2 dabrafenib 2 abemaciclib 2 Vorinostat 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Magnetic Resonance Spectroscopy 2 Immunotherapy, Adoptive 2 Imatinib Mesylate 2 Cyclophosphamide 2 Chlorotoxin 2 Cetuximab 2 Cancer Vaccines 2 Biopsy 2 vocimagene amiretrorepvec 1 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06258018 2024-08-30

ONC-2022-001

Istituto Clinico Humanitas

Phase 1/2 Not yet recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡